BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29155984)

  • 21. Cardiac troponin T concentrations above the 99th percentile value as measured by a new high-sensitivity assay predict long-term prognosis in patients with acute coronary syndromes undergoing routine early invasive strategy.
    Celik S; Giannitsis E; Wollert KC; Schwöbel K; Lossnitzer D; Hilbel T; Lehrke S; Zdunek D; Hess A; Januzzi JL; Katus HA
    Clin Res Cardiol; 2011 Dec; 100(12):1077-85. PubMed ID: 21792561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between serum S100A1 level and Global Registry of Acute Coronary Events score in patients with non-ST-segment elevation acute coronary syndrome.
    Li Y; Han C; Zhang P; Zang W; Guo R
    J Int Med Res; 2018 Jul; 46(7):2670-2678. PubMed ID: 29761721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.
    Gehrie ER; Reynolds HR; Chen AY; Neelon BH; Roe MT; Gibler WB; Ohman EM; Newby LK; Peterson ED; Hochman JS
    Am Heart J; 2009 Oct; 158(4):688-94. PubMed ID: 19781432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ST-segment depression in non-ST elevation acute coronary syndromes: quantitative analysis may not provide incremental prognostic value beyond comprehensive risk stratification.
    Yan AT; Yan RT; Tan M; Chow CM; Fitchett DH; Georgescu AA; Hassan Q; Luchansky J; Langer A; Goodman SG;
    Am Heart J; 2006 Aug; 152(2):270-6. PubMed ID: 16875907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of using exosome-derived cysteine-rich protein 61 as biomarkers for acute coronary syndrome.
    Li W; Li Y; Zhi W; Liu C; Fan W; Miao Q; Gu X
    Exp Ther Med; 2021 Dec; 22(6):1437. PubMed ID: 34721679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
    Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
    Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical criteria replenish high-sensitive troponin and inflammatory markers in the stratification of patients with suspected acute coronary syndrome.
    Stähli BE; Yonekawa K; Altwegg LA; Wyss C; Hof D; Fischbacher P; Brauchlin A; Schulthess G; Krayenbühl PA; von Eckardstein A; Hersberger M; Neidhart M; Gay S; Novopashenny I; Wolters R; Frank M; Wischnewsky MB; Lüscher TF; Maier W
    PLoS One; 2014; 9(6):e98626. PubMed ID: 24892556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome.
    Taglieri N; Dall'Ara G; Rapezzi C; Saia F; Cinti L; Rosmini S; Alessi L; Vagnarelli F; Moretti C; Palmerini T; Marrozzini C; Montefiori M; Branzi A; Marzocchi A
    J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):430-7. PubMed ID: 22772600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of prognostic significance between serum fibrinogen and Global Registry of Acute Coronary Events score for prognosis of patients with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention.
    Song J; Yu T; Sun Z; Li Z; He D; Sun Z
    Coron Artery Dis; 2020 Mar; 31(2):124-129. PubMed ID: 31833946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease.
    Andersson HB; Pedersen F; Engstrøm T; Helqvist S; Jensen MK; Jørgensen E; Kelbæk H; Räder SBEW; Saunamäki K; Bates E; Grande P; Holmvang L; Clemmensen P
    Eur Heart J; 2018 Jan; 39(2):102-110. PubMed ID: 29029035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study).
    Fox KA; Carruthers KF; Dunbar DR; Graham C; Manning JR; De Raedt H; Buysschaert I; Lambrechts D; Van de Werf F
    Eur Heart J; 2010 Nov; 31(22):2755-64. PubMed ID: 20805110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Risk Stratification of Patients Undergoing Coronary Angiography According to the Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention.
    Zafrir B; Adawi S; Khalaily M; Jaffe R; Eitan A; Barnett-Griness O; Saliba W
    J Am Heart Assoc; 2019 Jul; 8(14):e012433. PubMed ID: 31271083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The additive value of copeptin for early diagnosis and prognosis of acute coronary syndromes.
    Ahmed TAN; Johny JS; Abdel-Malek MY; Fouad DA
    Am J Emerg Med; 2021 Dec; 50():413-421. PubMed ID: 34481261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Value of sLOX-1 Level in Acute Coronary Syndromes Based on Thrombolysis in Myocardial Infarction Risk Score and Clinical Outcome.
    Mashayekhi S; Ziaee M; Garjani A; Sarbakhsh P; Ghaffari S
    J Emerg Med; 2018 Sep; 55(3):390-398. PubMed ID: 30049431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-941 as a promising biomarker for acute coronary syndrome.
    Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
    BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suspected ACS Patients Presenting With Myocardial Damage or a Type 2 Myocardial Infarction Have a Similar Late Mortality to Patients With a Type 1 Myocardial Infarction: A Report From the Australian and New Zealand 2012 SNAPSHOT ACS Study.
    Etaher A; Chew D; Redfern J; Briffa T; Ellis C; Hammett C; Lefkovits J; Elliott J; Cullen L; Brieger D; French JK
    Heart Lung Circ; 2017 Oct; 26(10):1051-1058. PubMed ID: 28139353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA) in patients with hypertrophic cardiomyopathy.
    Puwanant S; Trongtorsak A; Wanlapakorn C; Songsirisuk N; Ariyachaipanich A; Boonyaratavej S
    BMC Cardiovasc Disord; 2021 Nov; 21(1):556. PubMed ID: 34798824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic Accuracy of a New High-Sensitivity Troponin I Assay and Five Accelerated Diagnostic Pathways for Ruling Out Acute Myocardial Infarction and Acute Coronary Syndrome.
    Greenslade JH; Carlton EW; Van Hise C; Cho E; Hawkins T; Parsonage WA; Tate J; Ungerer J; Cullen L
    Ann Emerg Med; 2018 Apr; 71(4):439-451.e3. PubMed ID: 29248334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-Sensitivity Cardiac Troponin for Risk Assessment in Patients With Chronic Coronary Artery Disease.
    Wereski R; Adamson P; Shek Daud NS; McDermott M; Taggart C; Bularga A; Kimenai DM; Lowry MTH; Tuck C; Anand A; Lowe DJ; Chapman AR; Mills NL
    J Am Coll Cardiol; 2023 Aug; 82(6):473-485. PubMed ID: 37532417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.